231 related articles for article (PubMed ID: 22011062)
1. Case of atypical bullous pemphigoid with generalized pruritus and eczema as the prodrome for 10 years.
Ikeda T; Okamoto K; Furukawa F
J Dermatol; 2012 Aug; 39(8):720-1. PubMed ID: 22011062
[No Abstract] [Full Text] [Related]
2. Bullous pemphigoid masquerading as recurrent vesicular hand eczema.
Veien NK
Acta Derm Venereol; 2010; 90(1):4-5. PubMed ID: 20107717
[No Abstract] [Full Text] [Related]
3. Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid.
Kamiya K; Aoyama Y; Noda K; Miyake T; Yamaguchi M; Hamada T; Tokura Y; Iwatsuki K
J Dermatol Sci; 2015 Apr; 78(1):77-9. PubMed ID: 25771164
[No Abstract] [Full Text] [Related]
4. Type XVII collagen ELISA indices significantly decreased after bullous pemphigoid remission.
Kusajima E; Akiyama M; Sato M; Natsuga K; Shimizu H
Int J Dermatol; 2011 Feb; 50(2):238-40. PubMed ID: 21244398
[No Abstract] [Full Text] [Related]
5. Isolated NC16a-ELISA testing is of little value to identify bullous pemphigoid in elderly patients with chronic pruritus.
Hofmann SC; Otto C; Bruckner-Tuderman L; Borradori L
Eur J Dermatol; 2009; 19(6):634-5. PubMed ID: 19620033
[No Abstract] [Full Text] [Related]
6. Dyshidrosiform palmoplantar pemphigoid in a young man: response to dapsone.
Lupi F; Masini C; Ruffelli M; Puddu P; Cianchini G
Acta Derm Venereol; 2010; 90(1):80-1. PubMed ID: 20107732
[No Abstract] [Full Text] [Related]
7. A case of pemphigoid vegetans with autoantibodies against both BP180 and BP230 antigens.
Suda-Takayanagi T; Hara H; Ohyama B; Hashimoto T; Terui T
J Am Acad Dermatol; 2011 Jan; 64(1):206-8. PubMed ID: 21167421
[No Abstract] [Full Text] [Related]
8. Circulating IgE anti-BP180 autoantibody and its correlation to clinical and laboratorial aspects in bullous pemphigoid patients.
Ma L; Wang M; Wang X; Chen X; Zhu X
J Dermatol Sci; 2015 Apr; 78(1):76-7. PubMed ID: 25797173
[No Abstract] [Full Text] [Related]
9. A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180.
Osawa M; Ueda-Hayakawa I; Isei T; Yoshimura K; Fukuda S; Hashimoto T; Okamoto H
J Am Acad Dermatol; 2014 Jun; 70(6):e129-31. PubMed ID: 24831331
[No Abstract] [Full Text] [Related]
10. Biological and Clinical Response to Omalizumab in a Patient with Bullous Pemphigoid.
Menzinger S; Kaya G; Schmidt E; Fontao L; Laffitte E
Acta Derm Venereol; 2018 Feb; 98(2):284-286. PubMed ID: 29136264
[No Abstract] [Full Text] [Related]
11. Autoantibody serum levels and intensity of pruritus in bullous pemphigoid.
Bardazzi F; Barisani A; Magnano M; Tengattini V; La Placa M; Patrizi A; Balestri R
Eur J Dermatol; 2016 Aug; 26(4):390-1. PubMed ID: 27210833
[No Abstract] [Full Text] [Related]
12. Elevated levels of circulating immunoglobulin E autoantibodies against BP180 and BP230 in an intractable case of bullous pemphigoid.
Akasaka E; Hagiwara C; Takiyoshi N; Aizu T; Nakano H; Sawamura D; Ota T
J Dermatol Sci; 2016 Oct; 84(1):110-113. PubMed ID: 27492811
[No Abstract] [Full Text] [Related]
13. Bullous Pemphigoid in Three Paediatric Patients in Finland.
Pankakoski A; Panelius J; Salava A; Kluger N
Acta Derm Venereol; 2020 Mar; 100(6):adv00086. PubMed ID: 32157316
[No Abstract] [Full Text] [Related]
14. Methotrexate is safe and efficient as long-term treatment for bullous pemphigoid.
Delaumenie S; Assikar S; Prudhomme R; Matei I; Souyri N; Dalmay F; Bedane C
Eur J Dermatol; 2019 Apr; 29(2):217-218. PubMed ID: 30734720
[No Abstract] [Full Text] [Related]
15. A new clinical variant of acquired reactive perforating dermatosis-like bullous pemphigoid.
Schauer F; Kern JS; Virtic O; Technau-Hafsi K; Meiss F; Thoma K; Athanasiou I; Sitaru C; Di Zenzo G; Izumi K; Nishie W; Shimizu H; Bruckner-Tuderman L; Kiritsi D
Br J Dermatol; 2019 Jan; 180(1):231-232. PubMed ID: 30188568
[No Abstract] [Full Text] [Related]
16. Elevated IL-31 serum levels in bullous pemphigoid patients correlate with eosinophil numbers and are associated with BP180-IgE.
Salz M; Haeberle S; Hoffmann J; Enk AH; Hadaschik EN
J Dermatol Sci; 2017 Sep; 87(3):309-311. PubMed ID: 28823642
[No Abstract] [Full Text] [Related]
17. Peristomal bullous pemphigoid.
Marzano AV; Vezzoli P; Colombo A; Serini SM; Crosti C; Berti E
J Dermatol; 2010 Sep; 37(9):840-2. PubMed ID: 20883375
[No Abstract] [Full Text] [Related]
18. Bullous pemphigoid-like eruption subsequent to scabies: bullous scabies or bullous pemphigoid?
Huang MX; Li ZS; Luo DQ; Lin Q
G Ital Dermatol Venereol; 2015 Jun; 150(3):337-9. PubMed ID: 25658439
[No Abstract] [Full Text] [Related]
19. Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab.
Fairley JA; Baum CL; Brandt DS; Messingham KA
J Allergy Clin Immunol; 2009 Mar; 123(3):704-5. PubMed ID: 19152970
[No Abstract] [Full Text] [Related]
20. Bullous pemphigoid with hyperkeratosis and palmoplantar keratoderma: Three cases.
Fania L; Didona D; Pacifico V; Mariotti F; De Luca N; Abeni D; Mazzanti C; Di Zenzo G; Didona B
J Dermatol; 2018 Sep; 45(9):1135-1140. PubMed ID: 30007013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
